• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过半定性深入访谈识别 SSc-ILD 的未满足需求。

Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews.

机构信息

Department of Rheumatology, Oslo University Hospital, Oslo, Norway.

Department of Respiratory Disease and Allergy, Centre for Rare Lung Diseases, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Rheumatology (Oxford). 2021 Dec 1;60(12):5601-5609. doi: 10.1093/rheumatology/keab154.

DOI:10.1093/rheumatology/keab154
PMID:33587103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8788003/
Abstract

OBJECTIVES

Interstitial lung disease is frequent in SSc (SSc-ILD) and associates with significantly reduced quality of life. Here we aimed to analyse patient pathways, and experiences of patients and healthcare providers (HCPs) in order to identify unmet needs in the management of SSc-ILD patients.

METHODS

Semi-structured qualitative interviews conducted in eight European countries looked at HCP (n = 95) and patient perspectives (n = 47) using two sets of 70 research questions. Pre-diagnostic, diagnostic and post-diagnostic phases of the patient pathway were systematically explored.

RESULTS

(i) In the pre-diagnostic phase several gaps were identified by HCPs and patients in all participating countries: limited disease knowledge among primary care physicians and specialists, lack of accurate patient information, and delayed and/or inappropriate referral. (ii) The diagnostic phase is in most countries coordinated by rheumatologists, who are also the main point of care. Depending on the local health system, organization of multidisciplinary collaboration varies. HCPs issued lack of national guidelines, while patients stated difficulties obtaining disease-related information. (iii) In the post-diagnostic phase, HCPs and patients indicated lack of curative treatment, specialized nurses, and paramedical  and psychological support. Patients and caregivers additionally expressed the need for clear information on SSc-ILD.

CONCLUSION

Lack of disease specific knowledge, gaps in national healthcare systems and insufficient information and support for patients and caregivers were identified as unmet needs to ensure timely diagnosis, provide better patient management and to improve quality of life in SSc-ILD patients.

摘要

目的

系统性硬化症(SSc)常伴有间质性肺病(SSc-ILD),显著降低患者的生活质量。本研究旨在分析 SSc-ILD 患者的诊疗流程,并评估患者和医护人员的体验,以明确 SSc-ILD 患者的未满足需求。

方法

在 8 个欧洲国家开展半结构式定性访谈,纳入医护人员(n=95)和患者(n=47),采用 2 套共 70 个研究问题。系统评估患者诊疗流程的诊断前、诊断中和诊断后阶段。

结果

(i)在诊断前阶段,所有参与国家的医护人员和患者均发现存在多个差距:初级保健医生和专科医生对疾病的了解有限,缺乏准确的患者信息,以及转诊延误和/或不恰当。(ii)在诊断阶段,大多数国家均由风湿病学家协调,他们也是主要的治疗点。根据当地的卫生系统,多学科协作的组织形式存在差异。医护人员认为缺乏国家指南,而患者表示难以获得与疾病相关的信息。(iii)在诊断后阶段,医护人员和患者均表示缺乏有效的治疗方法、专门的护士以及辅助医疗和心理支持。患者和照护者还表示需要明确的 SSc-ILD 信息。

结论

疾病特异性知识缺乏、国家卫生系统存在差距以及患者和照护者的信息和支持不足,这些均是未满足的需求,可能导致 SSc-ILD 患者的诊疗延误,需要采取措施以改善患者的管理和生活质量。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/39e05dbf58fa/keab154f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/78e366a83201/keab154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/9a90d674f277/keab154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/898ac3f0f20b/keab154f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/39e05dbf58fa/keab154f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/78e366a83201/keab154f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/9a90d674f277/keab154f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/898ac3f0f20b/keab154f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c60a/8788003/39e05dbf58fa/keab154f4.jpg

相似文献

1
Identifying unmet needs in SSc-ILD by semi-qualitative in-depth interviews.通过半定性深入访谈识别 SSc-ILD 的未满足需求。
Rheumatology (Oxford). 2021 Dec 1;60(12):5601-5609. doi: 10.1093/rheumatology/keab154.
2
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.未言明之事:系统性硬化症患者、其照护者和医疗保健专业人员之间未讨论的重要议题——话语分析。
Clin Rheumatol. 2021 Apr;40(4):1399-1407. doi: 10.1007/s10067-020-05371-2. Epub 2020 Sep 11.
3
Challenges in physician-patient communication for optimal management of systemic sclerosis-associated interstitial lung disease: a discourse analysis.系统性硬化症相关间质性肺病优化管理中医生-患者沟通的挑战:一项话语分析
Clin Rheumatol. 2020 Oct;39(10):2989-2998. doi: 10.1007/s10067-020-05063-x. Epub 2020 Apr 13.
4
The need for a holistic approach for SSc-ILD - achievements and ambiguity in a devastating disease.需要采用整体方法治疗 SSc-ILD - 一种毁灭性疾病的成就与困惑。
Respir Res. 2020 Jul 23;21(1):197. doi: 10.1186/s12931-020-01459-0.
5
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病:基于个体化医学的系统性硬化症相关间质性肺病(SSc-ILD)预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
6
[Lung involvement in systemic sclerosis].[系统性硬化症中的肺部受累]
Rev Med Suisse. 2015 Apr 8;11(469):802-6.
7
The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study.丹麦自身免疫性风湿性疾病相关间质性肺疾病患者的诊断轨迹:一项基于访谈的研究。
Eur Clin Respir J. 2023 Mar 3;10(1):2178601. doi: 10.1080/20018525.2023.2178601. eCollection 2023.
8
Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study.8 个欧洲国家系统性硬化症相关间质性肺病的经济负担和管理:BUILDup Delphi 共识研究。
Adv Ther. 2021 Jan;38(1):521-540. doi: 10.1007/s12325-020-01541-5. Epub 2020 Nov 6.
9
[Systemic sclerosis-related interstitial lung disease: Diagnostic and therapeutic strategy in the light of recent clinical trials].[系统性硬化症相关间质性肺疾病:基于近期临床试验的诊断与治疗策略]
Rev Med Interne. 2022 Jun;43(6):365-374. doi: 10.1016/j.revmed.2021.12.003. Epub 2022 Feb 15.
10
Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.英国系统性硬化症相关间质性肺病患者的医疗资源利用情况:一项回顾性数据库分析。
Adv Ther. 2020 May;37(5):2460-2476. doi: 10.1007/s12325-020-01330-0. Epub 2020 Apr 21.

引用本文的文献

1
Patient perspectives on educational needs in scleroderma-interstitial lung disease.硬皮病-间质性肺疾病患者对教育需求的看法。
J Scleroderma Relat Disord. 2025 Jan 6:23971983241303655. doi: 10.1177/23971983241303655.
2
Multidisciplinary teams in the clinical care of fibrotic interstitial lung disease: current perspectives.纤维化间质性肺疾病临床护理中的多学科团队:当前观点
Eur Respir Rev. 2022 Sep 7;31(165). doi: 10.1183/16000617.0003-2022. Print 2022 Sep 30.
3
Development of a Patient Journey Map for Improving Patient Experience and Quality of Atopic Dermatitis Care.

本文引用的文献

1
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.系统性硬化症中间质性肺疾病的识别与管理:基于证据的欧洲共识声明
Lancet Rheumatol. 2020 Feb;2(2):e71-e83. doi: 10.1016/S2665-9913(19)30144-4. Epub 2020 Jan 14.
2
The Scleroderma Research Topics Survey for patients and health care professionals: A Scleroderma Patient-centered Intervention Network Project.面向患者和医护人员的硬皮病研究主题调查:硬皮病以患者为中心的干预网络项目
J Scleroderma Relat Disord. 2019 Oct;4(3):165-172. doi: 10.1177/2397198319842969. Epub 2019 Apr 23.
3
Things left unsaid: important topics that are not discussed between patients with systemic sclerosis, their carers and their healthcare professionals-a discourse analysis.
绘制患者就医流程图以改善特应性皮炎护理的患者体验和质量
Dermatol Ther (Heidelb). 2024 Feb;14(2):505-519. doi: 10.1007/s13555-024-01100-8. Epub 2024 Feb 9.
4
Variation in information needs of patients with interstitial lung disease and their family caregivers according to long-term oxygen therapy: a descriptive study.根据长期氧疗,特发性肺纤维化患者及其家庭照护者的信息需求存在差异:一项描述性研究。
BMC Pulm Med. 2023 Dec 5;23(1):486. doi: 10.1186/s12890-023-02795-9.
5
Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease.纤维性间质性肺病患者在欧洲经济区的疾病负担和生产力损失。
Adv Ther. 2023 Dec;40(12):5502-5518. doi: 10.1007/s12325-023-02701-z. Epub 2023 Oct 14.
6
The diagnostic trajectories of Danish patients with autoimmune rheumatologic disease associated interstitial lung disease: an interview-based study.丹麦自身免疫性风湿性疾病相关间质性肺疾病患者的诊断轨迹:一项基于访谈的研究。
Eur Clin Respir J. 2023 Mar 3;10(1):2178601. doi: 10.1080/20018525.2023.2178601. eCollection 2023.
7
Understanding the challenges, unmet needs, and expectations of mucopolysaccharidoses I, II and VI patients and their caregivers in France: a survey study.了解法国黏多糖贮积症 I、II 和 VI 患者及其照护者的挑战、未满足的需求和期望:一项调查研究。
Orphanet J Rare Dis. 2022 Dec 23;17(1):448. doi: 10.1186/s13023-022-02593-2.
8
Reporting and conducting patient journey mapping research in healthcare: A scoping review.报告和开展医疗保健患者就医流程研究:范围综述。
J Adv Nurs. 2023 Jan;79(1):83-100. doi: 10.1111/jan.15479. Epub 2022 Nov 3.
9
Patient preferences for the treatment of systemic sclerosis-associated interstitial lung disease: a discrete choice experiment.患者对系统性硬化症相关间质性肺病治疗的偏好:一项离散选择实验。
Rheumatology (Oxford). 2022 Oct 6;61(10):4035-4046. doi: 10.1093/rheumatology/keac126.
10
Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries.六个欧洲国家间质性肺疾病的流行病学及其进行性纤维化行为
ERJ Open Res. 2022 Jan 24;8(1). doi: 10.1183/23120541.00597-2021. eCollection 2022 Jan.
未言明之事:系统性硬化症患者、其照护者和医疗保健专业人员之间未讨论的重要议题——话语分析。
Clin Rheumatol. 2021 Apr;40(4):1399-1407. doi: 10.1007/s10067-020-05371-2. Epub 2020 Sep 11.
4
Patient and Physician Perspectives on Systemic Sclerosis-Associated Interstitial Lung Disease.患者与医生对系统性硬化症相关间质性肺病的看法
Clin Med Insights Circ Respir Pulm Med. 2020 Mar 18;14:1179548420913281. doi: 10.1177/1179548420913281. eCollection 2020.
5
Multidimensional tracking of phenotypes and organ involvement in a complete nationwide systemic sclerosis cohort.多维度追踪表型和器官受累在一个完整的全国系统性硬化症队列。
Rheumatology (Oxford). 2020 Oct 1;59(10):2920-2929. doi: 10.1093/rheumatology/keaa026.
6
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database.局限性皮肤系统性硬化症患者的结局:来自 EUSTAR 数据库的超过 12000 例患者的结果。
Autoimmun Rev. 2020 Feb;19(2):102452. doi: 10.1016/j.autrev.2019.102452. Epub 2019 Dec 12.
7
Gaps in care of patients living with pulmonary fibrosis: a joint patient and expert statement on the results of a Europe-wide survey.肺纤维化患者护理中的差距:患者与专家关于全欧洲范围调查结果的联合声明
ERJ Open Res. 2019 Oct 21;5(4). doi: 10.1183/23120541.00124-2019. eCollection 2019 Oct.
8
Current and future perspectives on management of systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关间质性肺病的管理:现状和未来展望。
Expert Rev Clin Immunol. 2019 Oct;15(10):1009-1017. doi: 10.1080/1744666X.2020.1668269. Epub 2019 Sep 30.
9
How do patients with systemic sclerosis experience currently provided healthcare and how should we measure its quality?系统性硬皮病患者目前所获得的医疗服务体验如何,我们应该如何衡量其质量?
Rheumatology (Oxford). 2020 Jun 1;59(6):1226-1232. doi: 10.1093/rheumatology/kez417.
10
Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.追踪系统性硬化症中肺间质疾病的影响:一项全国性完整队列研究。
Am J Respir Crit Care Med. 2019 Nov 15;200(10):1258-1266. doi: 10.1164/rccm.201903-0486OC.